AHA26: Plozasiran maintains TG-lowering efficacy alongside GLP-1RAs
Plozasiran maintains TG-lowering efficacy alongside GLP-1RAs, supporting its use with multiple cardiometabolic therapies.
Plozasiran maintains TG-lowering efficacy alongside GLP-1RAs, supporting its use with multiple cardiometabolic therapies.